FOI release

Freedom of Information responses from the MHRA - week commencing 12 July 2021

The Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 12 July 2021

From:
Medicines and Healthcare products Regulatory Agency
Published
29 December 2021
Last updated
27 April 2022 — See all updates

Documents

Freedom of Information request on breakdown by age for other types of ADR similarly to Thrombo-Embolic events (FOI 21-669)

HTML

Freedom of Information request on the adverse incidents arising from COVID-10 testing and the legal requirements on labelling a diagnostic test (FOI 21-670)

HTML

Freedom of Information request on a copy of the minutes from the Gastroenterology, Rheumatology, Immunology and Dermatology Expert Advisory Group (GRID EAG) meeting (FOI 21-676)

HTML

Freedom of Information request on how many deaths, hospitalisations, and disabilities have occurred within 28 days of any of the COVID-19 vaccinations (FOI 21-677)

HTML

Freedom of Information request on the details of all suspected reactions for Zostavax, Boostrix IPV, Gardasil and Bexsero (FOI 21-679)

HTML

Freedom of Information request on the numbers, broken down by month and age at the time of death, of vaccine related deaths covering the inclusive period 01/03/2016 to 31/05/2021 (FOI 21-680)

HTML

Freedom of Information request on the data presented weekly in MHRA's Summary of Yellow Card reporting in association with the COVID-19 vaccination campaign (FOI 21-694)

HTML

Freedom of Information request on access to data from January - December 2020 with regards to ADRs reported as a result of hydroxychloroquine use for treatment of COVID-19 (FOI 21-702)

HTML

Freedom of Information request on Yellow Card Drug Analysis Profiles (iDAPs) (FOI 21-719)

HTML

Freedom of Information request on the study protocol, amendments, related study manuals and clinical study report for clinical trial GS-US-174-0149 (FOI 21-732)

HTML

Freedom of Information request on the safety of vaccine excipients (FOI 21-710)

HTML

Freedom of Information request on VAERS for reporting adverse reactions (FOI 21-724)

HTML

Freedom of Information request one total number of events and deaths by batch number for the AstraZeneca COVID-19 vaccine and the respective date of administration and location when a fatal outcome was reported (FOI 21-735)

HTML

Freedom of Information request on the suspected reactions for the Shingles vaccine (FOI 21-743)

HTML

Freedom of Information request on any studies concerning the mixing of the vaccines (FOI 21-769)

HTML

Freedom of Information request on the total numbers of deaths for COViID-19 vaccine from December 2020 to date and the number of recorded deaths within 28 days of a COVID-19 vaccine (FOI 21-778)

HTML

PDF, 69.3 KB, 37 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 56.6 KB, 32 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 117 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 110 KB, 49 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 67.5 KB, 33 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 14.4 KB, 1 page

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 117 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 69.3 KB, 37 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 12 July 2021

Updates to this page

Published 29 December 2021
Last updated 27 April 2022 show all updates

  1. Uploaded FOI's for the 13th, 14th and 16th July.

  2. First published.

Sign up for emails or print this page

Related content